Aprea Therapeutics Inc

1
NAS:APRE (USA)  
$ 6.79 +0.36 (+5.82%) 11:09 PM EST
At Loss
P/B:
1.21
Market Cap:
$ 25.37M
Enterprise V:
$ -5.62M
Volume:
28.06K
Avg Vol (2M):
44.44K
Volume:
28.06K
At Loss
Avg Vol (2M):
44.44K

Business Description

Aprea Therapeutics Inc
NAICS : 325412 SIC : 2836
ISIN : US03836J2015
Description
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.79
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 55.9
9-Day RSI 51.17
14-Day RSI 51.46
6-1 Month Momentum % 41.8
12-1 Month Momentum % 12.73

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.15
Quick Ratio 6.15
Cash Ratio 6.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -36.2
Shareholder Yield % -24.99

Financials (Next Earnings Date:2024-03-29 Est.)

APRE's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:APRE

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Aprea Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.99
Beta 1.7
Volatility % 81.71
14-Day RSI 51.46
14-Day ATR ($) 0.786306
20-Day SMA ($) 7.02368
12-1 Month Momentum % 12.73
52-Week Range ($) 2.78 - 8.8465
Shares Outstanding (Mil) 3.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aprea Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Aprea Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Aprea Therapeutics Inc Frequently Asked Questions

What is Aprea Therapeutics Inc(APRE)'s stock price today?
The current price of APRE is $6.79. The 52 week high of APRE is $8.85 and 52 week low is $2.78.
When is next earnings date of Aprea Therapeutics Inc(APRE)?
The next earnings date of Aprea Therapeutics Inc(APRE) is 2024-03-29 Est..
Does Aprea Therapeutics Inc(APRE) pay dividends? If so, how much?
Aprea Therapeutics Inc(APRE) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1